A close association between alteration in growth kinetics by neoadjuvant chemotherapy and survival outcome in primary breast cancer.

International journal of oncology

Volumn 25, Issue 2, 2004, Pages 397-405

  Takada, Masahiro ^a   Kataoka, Akemi ^a   Toi, Masakazu ^a   Bando, Hiroko ^a   Toyama, Kazumi ^a   Horiguchi, Shinichiro ^a   Ueno, Takayuki ^a   Linder, Stig ^a   Saji, Shigehira ^a   Hayashi, Yukiko ^a   Funata, Nobuaki ^a   Kinoshita, Junko ^a   Murakami, Sigeru ^a   Ohono, Shinji ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; KERATIN; KI 67 ANTIGEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; IMMUNOLOGY; KINETICS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL; TUMOR CELL LINE;

ADULT; AGED; ANTIBODIES, NEOPLASM; BREAST NEOPLASMS; CELL LINE, TUMOR; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; KERATINS; KI-67 ANTIGEN; KINETICS; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 16644375439     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.25.2.397     Document Type: Article

References (0)